Citation Impact
Citing Papers
[125]I-Spectramide: A novel benzamide displaying potent and selective effects at the D2 dopamine receptor
1989
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled Trial
2007 Standout
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Brain-Derived Tumor Necrosis Factor-α and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant
2004
Differences in the Ligand Binding Properties of the Short and Long Versions of the D2 Dopamine Receptor
1993
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Influence of Dopamine on Limbic Inputs to the Nucleus Accumbens
1988
Getting Formal with Dopamine and Reward
2002 Standout
Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo
1994 StandoutNobel
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
2009 Standout
Striatal D2 Dopamine Receptor Characteristics in Neuroleptic-Naive Schizophrenic Patients Studied With Positron Emission Tomography
1994
Association of dopamine d, and d2 receptors with specific cellular elements in the basal ganglia of the cat: The uneven topography of dopamine receptors in the striatum is determined by intrinsic striatal cells, not nigrostriatal axons
1988
Localized intracaudate dopamine D2 receptor activation during the post-training period improves memory for visual or olfactory conditioned emotional responses in rats
1991
Food reward: Brain substrates of wanting and liking
1996 Standout
The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide
1988 StandoutNobel
Effects of the substituted (S)-3-phenylpiperidine (−)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains
1999 StandoutNobel
Psychedelics
2016 Standout
Acute phase proteins in major depression
1997
Network interactions in schizophrenia — therapeutic implications
2000 StandoutNobel
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
1998 Standout
Cytokines sing the blues: inflammation and the pathogenesis of depression
2005 Standout
Α Review on the Acute Phase Response in Major Depression
1993
Increased serum interleukin-1-receptor-antagonist concentrations in major depression
1995
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
1990 StandoutNature
A dopaminergic inhibitory postsynaptic potential mediated by an increased potassium conductance
1989
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum
1989 StandoutNobel
Elevated levels of acute phase plasma proteins in major depression
1992
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
The current status of the platelet 5-HT2A receptor in depression
2000
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Positive and negative acute phase proteins in affective subtypes
1998
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
2003 StandoutNature
Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
2000 Standout
Dopamine neurons projecting to the medial prefrontal cortex possess release-modulating autoreceptors
1987
Acute changes in dopamine levels in rat adrenal glands after administration of dopamine receptor agonists and antagonists
1990 StandoutNobel
The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study
1993 StandoutNobel
Neurobiology of Depression
2002 Standout
The Mechanism of Action of Novel Antipsychotic Drugs
1991
Neurotransmitter interactions in schizophrenia—therapeutic implications
1999 StandoutNobel
Indicators of immune activation in major depression
1996
Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
1991 Standout
Changes in regional cerebral blood flow on recovery from depression
1995
Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression
1999
Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study
1997
Immune Activation During Pregnancy in Mice Leads to Dopaminergic Hyperfunction and Cognitive Impairment in the Offspring: A Neurodevelopmental Animal Model of Schizophrenia
2005
Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: An electrophysiological and behavioural study
1987
On the mechanism of neuroleptic induced increase in striatal dopamine release: Brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals
1989
MK-801-induced hyperlocomotion: Differential effects of M100907, SDZ PSD 958 and raclopride
1997 StandoutNobel
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Chronic pharmacological manipulation of dopamine receptors in brain
1987
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Reciprocal Limbic-Cortical Function and Negative Mood: Converging PET Findings in Depression and Normal Sadness
1999 Standout
Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine
1991 StandoutNature
3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms
1989
NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens
1992
Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs
1997
Dopamine, learning and motivation
2004 Standout
The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats
1986 StandoutNobel
Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens
1986
Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons
1987
D-1 dopamine receptors in the rat brain: a quantitative autoradiographic analysis
1986
Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: Localization to intrinsic neurons and not to neocortical afferents
1987
A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs
1985
Brain locations controlling the behavioral effects of chronic amphetamine intoxication
1980
3H-domperidone binding sites differ in rat striatum and pituitary
1984
Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
1985 Standout
Neuroleptic properties of cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide (YM-09151-2) with selective antidopaminergic activity
1981
Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: Drug interaction at presynaptic receptors?
1980
Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents
1995
Dopamine D2 receptors in brain and anterior pituitary recognize agonist and antagonist actions of (?)-3-PPP
1985
The electrophysiology of dopamine (D2) receptors: A study of the actions of dopamine on corticostriatal transmission
1983
Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat
1985
Ionic dependence of glutamate neurotoxicity
1987 Standout
Predictive Reward Signal of Dopamine Neurons
1998 Standout
The D-1 Dopamine Receptor and the Search for its Functional Role: From Neurochemistry to Behaviour
1987
Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats
1984
Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.
1981
Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats
1987
Electrophysiological responses of neurones in the nucleus accumbens to hippocampal stimulation and the attenuation of the excitatory responses by the mesolimbic dopaminergic system
1984
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta.
1987
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Some effects of pimozide on nondeprived rats' lever pressing maintained by a sucrose reward in an anhedonia paradigm
1987
Dopamine receptors involved in prolactin secretion pharmacologically characterized by means of 3-PPP enantiomers
1983 StandoutNobel
Behavioral Evidence of Depolarization Block of Dopamine Neurons after Chronic Treatment with Haloperidol and Clozapine
2000
Specific in vitro and in vivo binding of 3H-raclopride a potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain
1985
Identification of D-2 dopaminergic receptors in bovine adrenal cortex
1985
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Schizophrenia: Some Current Neurochemical Approaches
1983
Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain
1984
Regional distribution of sultopride and sulpiride in rat brain measured by radioimmunoassay
1983
Remoxipride, a new potential antipsychotic compound with selective anti-dopaminergic actions in the rat brain
1984
The Sympathetic Nerve—An Integrative Interface between Two Supersystems: The Brain and the Immune System
2000 Standout
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
1990 StandoutScience
Glutamate: A Neurotransmitter in Mammalian Brain
1984 Standout
Increased baseline occupancy of D 2 receptors by dopamine in schizophrenia
2000 Standout
Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons
1983 Science
In vivo presynaptic control of dopamine release in the cat caudate nucleus—II. Facilitatory or inhibitory influence ofl-glutamate
1986
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Dopamine Receptors: From Structure to Function
1998 Standout
BRL 20596, a novel anilide with central dopamine antagonist activity
1986 Nobel
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
1980 Nature
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Presynaptic dopaminergic modulation of cortical input to the striatum
1986
Differential Alteration of Striatal D-1 and D-2 Receptors Induced by the Long-Term Administration of Haloperidol, Sulpiride or Clozapine to Rats
1985
Works of A. Theodorou being referenced
Alpha-1-acid glycoprotein in major depressive and eating disorders
1991
Chronic neuroleptic treatment specifically alters the number of dopamine receptors in rat brain
1981
A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs
1978
Kainic acid lesions of striatum and decortication reduce specific [3H]sulpiride binding in rats, so D-2 receptors exist post-synaptically on corticostriate afferents and striatal neurons
1981
Alterations in cerebral dopamine function caused by administration ofcis- ortrans-flupenthixol for up to 18 months
1983
Chronic continuous administration of neuroleptic drugs alters cerebral dopamine receptors and increases spontaneous dopaminergic action in the striatum
1982 Nature
A comparison of striatal and mesolimbic dopamine function in the rat during 6-month trifluoperazine administration
1980
Increased striatal acetylcholine after 14 months cis-flupenthixol treatment in rats suggests functional supersensitivity of dopamine receptors
1982
Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months
1979 Nature
Subchronic treatment with the tricyclic antidepressant DMI increases isolation-induced fighting in rats
1981
Plasma noradrenaline, adrenaline and DHPG responses to clonidine in control and depressed subjects
1992
Stereoselective actions of substituted benzamide drugs on cerebral dopamine mechanisms
1980
Alpha 2-adrenoceptors in depression.
1987
Cation regulation differentiates specific binding of [3 H]sulpiride and [3 H]spiperone to rat striatal preparations
1980
Cation specificity of 3H-sulpiride binding involves alteration in the number of striatal binding sites
1983
Specific binding of [3H]sulpiride to rat striatal preparations
1979
Specific receptors for substituted benzamide drugs in brain.
1982